Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 17317858

Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2007 Jun 1
First author
Hehlmann R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Clin Pract Oncol. 2008 Jan;5(1):14-5. doi: 10.1038/ncponc0983.
    note
    Source null
    related pmid
    17940526
    relationship
    Comment in
  2. citation
    Blood. 2007 Dec 15;110(13):4618; author reply 4618-9. doi: 10.1182/blood-2007-07-098228.
    note
    Source null
    related pmid
    18056847
    relationship
    Comment in

Authors and identifiers

  1. name
    Hehlmann R
    type
    Author
  2. name
    Berger U
    type
    Author
  3. name
    Pfirrmann M
    type
    Author
  4. name
    Heimpel H
    type
    Author
  5. name
    Hochhaus A
    type
    Author
  6. name
    Hasford J
    type
    Author
  7. name
    Kolb HJ
    type
    Author
  8. name
    Lahaye T
    type
    Author
  9. name
    Maywald O
    type
    Author
  10. name
    Reiter A
    type
    Author
  11. name
    Hossfeld DK
    type
    Author
  12. name
    Huber C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hehlmann R
    type
    Author
  2. name
    Berger U
    type
    Author
  3. name
    Pfirrmann M
    type
    Author
  4. name
    Heimpel H
    type
    Author
  5. name
    Hochhaus A
    type
    Author
  6. name
    Hasford J
    type
    Author
  7. name
    Kolb HJ
    type
    Author
  8. name
    Lahaye T
    type
    Author
  9. name
    Maywald O
    type
    Author
  10. name
    Reiter A
    type
    Author
  11. name
    Hossfeld DK
    type
    Author
  12. name
    Huber C
    type
    Author
bibliography ids
  1. nci-bib-3c92b0b2f713fd0faa81dbf7
book metadata
content sha256
ffbbf3168cb2714eb35820692f48fd544cc36a10c8280442dcb9dfbcd4261194
document type
citation
dois
  1. 10.1182/blood-2006-11-055186
electronic publication date
display
2007 Feb 22
precision
day
year
2007
evidence scope
bibliographic_metadata_only
id
pubmed:17317858
immutable id
pubmed:17317858@ffbbf3168cb2714eb35820692f48fd544cc36a10c8280442dcb9dfbcd4261194
journal
abbreviation
Blood
issn electronic
Source null
issn print
0006-4971
issue
11
name
Blood
nlm unique id
7603509
pages
4686-92
volume
109
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Clin Pract Oncol. 2008 Jan;5(1):14-5. doi: 10.1038/ncponc0983.
    note
    Source null
    related pmid
    17940526
    relationship
    Comment in
  2. citation
    Blood. 2007 Dec 15;110(13):4618; author reply 4618-9. doi: 10.1182/blood-2007-07-098228.
    note
    Source null
    related pmid
    18056847
    relationship
    Comment in
outcomes validated
false
pmid
17317858
provenance
batch id
e687ecc838c318f9ec65
provider
NCBI PubMed ESummary
record sha256
5b3dac2bf128d63394350f910a2a25d3c991c14264b00622b2f55de7a95c3bdd
response sha256
57c28819ed5384f58bd55b57a106357c87d58ddac21f26fe526ca7520d9f61c6
retrieved at
2026-09-09T23:46:11.674833+00:00
publication date
display
2007 Jun 1
precision
day
year
2007
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/17317858/
title
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.

Preserved source evidence · Not medical advice